Abstract
Effective and better-tolerated agents for the treatment of most of psychiatric disorders are one of the main challenges. Recently, anti-inflammatory, antioxidants and neuroprotective agents as adjuvant therapy have been shown to be able to play a role against the degenerative mechanisms commonly related to psychiatric conditions. Berberine, a biologically active alkaloid derived from various plants, represents many pharmacological impacts, such as antimicrobi-al, antidiabetic, anticancer, antioxidant and anti-inflammatory activities. This compound also protects neurons and improves the survival, growth and action of nerve cells due to its high potential for crossing the blood-brain barrier. Ample evidence reported that berberine had been associated with CNS-related disorders, including Alzheimer's, cerebral ischemia, mental depres-sion, schizophrenia and anxiety. Thus, in this review, we aimed to indicate the effectiveness of berberine on mental disorders. © 2023 Bentham Science Publishers.
Cite
CITATION STYLE
Shayganfard, M. (2022). Berberine: Is it a Promising Agent for Mental Disorders Treatment? Current Molecular Pharmacology, 16(3), 307–320. https://doi.org/10.2174/1874467215666220509213122
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.